| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 2.6e-05 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -7e-05 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |